Leong Samuel C, Lazarova Lepa, Tsang Hoo K, Banhegyi Gyorgy
Rhinology. 2015 Mar;53(1):35-40. doi: 10.4193/Rhino14.156.
Midfacial segment pain (MSP) has the characteristics of tension-type headache which is confined to the midface cor- responding to the second division of the trigeminal nerve. This review presents treatment outcomes of MSP patients managed at the Multi-disciplinary Team (MDT) Facial Pain Clinic in Liverpool.
Prospective clinical outcome performed in a tertiary referral centre for complex facial pain syndromes.
Sino-Nasal Outcome Test (SNOT). Clinical "success" was defined as an improvement in total SNOT score of >9 points and a reduction of the ear-facial symptoms sub-domain score by ≥50% from baseline.
The average age of the cohort was 49 years, with an average follow-up of 12 months. The overall pre-treatment total SNOT-22 score was 59.5 which improved significantly to 42 at latest follow-up. Although the average scores of all sub-domains improved, only the ear-facial symptoms and psychological issues sub-domains achieved statistical significance. When the criterion for success was applied, nine patients fulfilled this definition at an average of 12 months follow-up. The baseline total SNOT score in this cohort improved from 60.6 to 19.7. Half of these patients achieved success within 18 months of commencing treatment and the probability of attaining success at long-term follow-up was high.
Treatment of midfacial segment facial pain is complex and requires follow-up to achieve any meaningful clinical outcome.
面中段疼痛（MSP）具有紧张型头痛的特征，局限于对应三叉神经第二分支的面中部。本综述介绍了在利物浦多学科团队（MDT）面部疼痛诊所接受治疗的MSP患者的治疗结果。
在一家治疗复杂面部疼痛综合征的三级转诊中心进行前瞻性临床结果研究。
鼻-鼻窦结局测试（SNOT）。临床“成功”定义为SNOT总分改善超过9分，耳面部症状子域得分较基线降低≥50%。
该队列的平均年龄为49岁，平均随访12个月。治疗前SNOT-22总分平均为59.5，在最近一次随访时显著改善至42。虽然所有子域的平均得分均有所改善，但只有耳面部症状和心理问题子域具有统计学意义。采用成功标准时，9例患者在平均12个月的随访中达到该定义。该队列的基线SNOT总分从60.6提高到19.7。这些患者中有一半在开始治疗后的18个月内取得成功，长期随访时获得成功的概率很高。
面中段面部疼痛的治疗很复杂，需要随访才能取得任何有意义的临床结果。
